Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress

Journal of Psychiatric Research

Volumn 46, Issue 3, 2012, Pages 331-340

  Moretti, Morgana ^a   Colla, André ^a   De Oliveira Balen, Grasiela ^a   Dos Santos, Danúbia Bonfanti ^a   Budni, Josiane ^a   De Freitas, Andiara Espíndola ^a   Farina, Marcelo ^a   Severo Rodrigues, Ana Lúcia ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antioxidant; Ascorbic acid; Chronic unpredictable stress; Depression; Oxidative stress

Indexed keywords

ASCORBIC ACID; CATALASE; FLUOXETINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CHRONIC STRESS; CHRONIC UNPREDICTABLE STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; GROOMING; HIPPOCAMPUS; IMMOBILIZATION; LIPID PEROXIDATION; LOCOMOTION; MOUSE; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; TREATMENT RESPONSE;

EID: 84857141511     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.11.009     Document Type: Article

References (90)

1. Aebi H. Catalase in vitro. Methods in Enzymology 1984, 105:121-126.
2. Aguilera G. Corticotropin releasing hormone, receptor regulation and the stress response. Trends in Endocrinology & Metabolism 1998, 9:329-336.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, Washington, DC. 4th ed.
4. Bano S., Parihar M.S. Reduction of lipid peroxidation in different brain regions by a combination of α-tocopherol and ascorbic acid. Journal of Neural Transmission 1997, 104:1277-1286.
5. Benkovic S.A., Connor J.R. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. Neurology 1993, 338:97-113.
6. Berk M., Copolov D.L., Dean O., Lu K., Jeavons S., Schapkaitz I., et al. N-acetyl cysteine for depressive symptoms in bipolar disorder - a double-blind randomized placebo-controlled trial. Biological Psychiatry 2008, 64:468-475.
7. Bielajew C., Konkle A.T.M., Merali Z. The effects of chronic mild stress on male Sprague-Dawley and Long Evans rats: I. Biochemical and physiological analyses. Behavioural Brain Research 2002, 136:583-592.
8. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. Journal of Affective Disorders 2001, 64:43-51.
9. Binfaré R.W., Rosa A.O., Lobato K.R., Santos A.R.S., Rodrigues A.L.S. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Progress in Neuropsychopharmacology & Biological Psychiatry 2009, 33:530-540.
10. Blanchard R.J., Nikulina J.N., Sakai R.R., Mckittrick C., McEwen B., Blanchard C. Behavioral and endocrine change following chronic predatory stress. Physiology & Behavior 1998, 63:561-569.
11. Bondi C.O., Rodriguez G., Gould G.G., Frazer A., Morilak D.A. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 2008, 33:320-331.
12. Brocardo P.S., Assini F., Franco J.L., Pandolfo P., Müller Y.M., Takahashi R.N., et al. Zinc attenuates malathion-induced depressant-like behavior and confers neuroprotection in the rat brain. Toxicological Sciences 2007, 97:140-148.
13. Brocardo P.S., Budni J., Kaster M.P., Santos A.R., Rodrigues A.L.S. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 2008, 54:464-473.
14. Brocardo P.S., Budni J., Pavesi E., Franco J.L., Uliano-Silva M., Trevisan R., et al. Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain. Bipolar Disorder 2010, 12:414-424.
15. Brody S. High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial. Biological Psychiatry 2002, 52:371-374.
16. Carlberg I., Mannervik B. Glutathione reductase. Methods in Enzymology 1985, 113:484-490.
17. Charney D.S., Manji H.K. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Science's STKE 2004, 225:1-11.
18. Chen Y., Wang H.D., Xia X., Kung H.F., Pan Y., Kong L.D. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the chronic mild stress model of depression in mice. Phytomedicine 2007, 14:523-529.
19. Cocchi P., Silenzi M., Calabri G., Salvi G. Antidepressant effect of vitamin C. Pediatrics 1980, 65:862-863.
20. Critchlow V., Liebelt A., Barsela M., Mountcastle W., Lipscomb H.S. Sex differences in resting pituitary-adrenal function in the rat. American Journal of Physiology 1963, 205:807-815.
21. Curtis A.L., Bethea T., Valentino R.J. Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology 2006, 31:544-554.
22. de Vasconcellos A.P., Nieto F.B., Crema L.M., Diehl L.A., de Almeida L.M., Prediger M.E., et al. Chronic lithium treatment has antioxidant properties but does not prevent oxidative damage induced by chronic variate stress. Neurochemical Research 2006, 31:1141-1151.
23. Ellman G.L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 1959, 82:70-77.
24. Eren I., Naziroglu M., Demirdas A., Celik O., Uguz A.C., Altunbasak A., et al. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochemical Research 2007, 32:497-505.
25. Eren I., Naziroglu M., Demirdas A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochemical Research 2007, 32:1188-1195.
26. Fontella F.U., Siqueira I.R., Vasconcellos A.P.S., Tabajara A.S., Netto C.A., Dalmaz C. Repeated restraint stress induces oxidative damage in rat hippocampus. Neurochemical Research 2005, 30:105-111.
27. Fridovich I. Superoxide radical: an endogenous toxicant. Annual Review of Pharmacology and Toxicology 1983, 23:239-257.
28. Galecki P., Szemraj J., Zboralski K., Florkowski A., Lewinski A. Relation between functional polymorphism of catalase gene (-262C > T) and recurrent depressive disorder. Neuro Endocrinology Letters 2009, 30:357-362.
29. Gamaro G.D., Manoli L.P., Torres I.L., Silveira R., Dalmaz C. Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures. Neurochemistry International 2003, 42:107-114.
30. Garcia L.S., Comim C.M., Valvassori S.S., Réus G.Z., Stertz L., Kapczinski F., et al. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Progress in Neuropsychopharmacology & Biological Psychiatry 2009, 33:450-455.
31. Graumann R., Paris I., Martinez-Alvarado P., Rumanque P., Perez-Pastene C., Cardenas S.P., et al. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase. Polish Journal of Pharmacology 2002, 54:573-579.
32. Heim C., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008, 33:693-710.
33. Herken H., Gurel A., Selek S., Armutcu F., Ozen M.E., Bulut M., et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Archives of Medical Research 2007, 38:247-252.
34. Heuther G., Fettkotter I., Keihfoff G., Wolf G. Serotonin acts as a free radicals scavenger and is oxidized to a dimmer during the respiratory burst of activated microglia. Journal of Neurochemistry 1997, 69:2096-2101.
35. Isingrini E., Camus V., Le Guisquet A.M., Pingaud M., Devers S., Belzung C. Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice. PLoS ONE 2010, 5:e10404.
36. Kelner M.J., Bagnell R., Montoya M., Estes L., Uglik S.F., Cerutti P. Transfection with human copper-zinc superoxide dismutase induces bidirectional alterations in other antioxidant enzymes, proteins, growth factor response, and paraquat resistance. Free Radical Biology & Medicine 1995, 18:497-506.
37. Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin reuptake inhibitors. Redox Report 2003, 8:365-370.
38. Kitay J.I. Sex differences in adrenal cortical secretion in the rat. Endocrinology 1961, 68:818-824.
39. Kovachich G.B., Mishra O.P. The effect of ascorbic acid on malonaldehyde formation, K+, Na+ andwater content of brain slices. Experimental Brain Research 1983, 50:62-68.
40. Kumar B., Kuhad A., Chopra K. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences. Psychopharmacology (Berl) 2011, 214:819-828.
41. Larsen M.H., Mikkelsen J.D., Hay-Schmidt A., Sandi C. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. Journal of Psychiatric Research 2010, 44:808-816.
42. Laucher J., Delton I., Buda M., Tappaz M. The habituation of brainstem catecholaminergic groups to chronic daily restraint stress is stress specific like that of the hypothalamo-pituitary-adrenal axis. Brain Research 1994, 638:196-202.
43. Le Mevel J.C., Abitol S., Beraud G., Maniey J. Temporal changes in plasma adrenocorticotropin concentration after repeated neurotropic stress in male and female rats. Endocrinology 1979, 105:812-817.
44. Li N., Liu R.J., Dwyer J.M., Banasr M., Lee B., Son H., et al. Glutamate N-methyl-d-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biological Psychiatry 2011, 69:754-761.
45. Lin Y.H., Liu A.H., Xu Y., Tie L., Yu H.M., Li X.J. Effect of chronic unpredictable mild stress on brain-pancreas relative protein in rat brain and pancreas. Behavioural Brain Research 2005, 165:63-71.
46. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
47. Lu X.Y., Kim C.S., Frazer A., Zhang W. Leptin: a potential novel antidepressant. Proceedings of National Academy of Sciences of the United States of America 2006, 103:1593-1598.
48. Lucca G., Comim C.M., Valvassori S.S., Réus G.Z., Vuolo F., Petronilho F., et al. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochemistry International 2009, 54:358-362.
49. Madrigal J.L., Olivenza R., Moro M.A., Lizasoain I., Lorenzo P., Rodrigo J., et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001, 24:420-429.
50. Majewska M.D., Bell J.A. Ascorbic acid protects neurons from injury induced by glutamate and NMDA. Neuroreport 1990, 1:194-196.
51. Majewska M.D., Bell J.A., London E.D. Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Research 1990, 537:328-332.
52. Manoli L.P., Gamaro G.D., Silveira P.P., Dalmaz C. Effect of chronic variate stress on thiobarbituric-acid reactive species and on total radical-trapping potential in distinct regions of rat brain. Neurochemical Research 2000, 25:915-921.
53. Marin M.T., Cruz F.C., Planeta C.S. Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats. Physiology & Behavior 2007, 90:29-35.
54. Matés J.M., Sánchez-Jiménez F. Antioxidant enzymes and their implications in pathophysiologic processes. Frontiers in Bioscience 1999, 4:D339-D345.
55. Meister A., Anderson M.E. Glutathione. Annual Review of Biochemistry 1983, 52:711-760.
56. Moretti M., Freitas A.E., Budni J., Fernandes S.C., Balen G.D., Rodrigues A.L.S. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test. Behavioural Brain Research 2011, 225:328-333.
57. Nemeroff C.B. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. Journal of Psychiatric Research 2007, 41:189-206.
58. Nestler E.J., Barrot M., Dileone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
59. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. International Journal of Neuropsychopharmacology 2008, 11:851-876.
60. Nirmal J., Babu C.S., Harisudhan T., Ramanathan M. Evaluation of behavioural and antioxidant activity of Cytisus scoparius Link in rats exposed to chronic unpredictable mild stress. BMC Complementary and Alternative Medicine 2008, 8:15.
61. Noschang C.G., Pettenuzzo L.F., von Pozzer Toigo E., Andreazza A.C., Krolow R., Fachin A., et al. Sex-specific differences on caffeine consumption and chronic stress-induced anxiety-like behavior and DNA breaks in the hippocampus. Pharmacology Biochemistry and Behavior 2009, 94:63-69.
62. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979, 95:351-358.
63. Ozcan M.E., Gulec M., Ozerol E., Polat R., Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology 2004, 19:89-95.
64. Pandey G.N., Sharma R.J., Janicak P.G., Davis J.M. Monoamine oxidase and cortisol response in depression and schizophrenia. Psychiatry Research 1992, 44:1-8.
65. Pitman D.L., Ottenweller J.E., Natelson B.H. Effect of intensity on habituation and sensitization of glucocorticoid responses in rats. Behavioral Neuroscience 1990, 104:28-36.
66. Prediger M.E., Gamaro G.D., Crema L.M., Fontella F.U., Dalmaz C. Estradiol protects against oxidative stress induced by chronic variate stress. Neurochemical Research 2004, 29:1923-1930.
67. Rebec G.V., Pierce R.C. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Progress in Neurobiology 1994, 43:537-565.
68. Reynolds I.J., Hastings T.G. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. Journal of Neuroscience 1995, 15:3318-3327.
69. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends in Neuroscience 2000, 23:209-216.
70. Röhrdanz E., Obertrifter B., Ohler S., Tran-Thi Q., Kahl R. Influence of adriamycin and paraquat on antioxidant enzyme expression in primary rat hepatocytes. Archives of Toxicology 2000, 74:231-237.
71. Rosa A.O., Lin J., Calixto J.B., Santos A.R., Rodrigues A.L. Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behavioural Brain Research 2003, 144:87-93.
72. Rosa K.A., Gadotti V.M., Rosa A.O., Rodrigues A.L.S., Calixto J.B., Santos A.R.S. Evidence for the involvement of glutamatergic system in the antinociceptive effect of ascorbic acid. Neuroscience Letters 2005, 381:185-188.
73. Sanacora G., Zarate C.A., Krystal J.H., Manji H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nature Reviews Drug Discovery 2008, 7:426-437.
74. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
75. Santos I.M., Tomé Ada R., Saldanha G.B., Ferreira P.M., Militão G.C., Freitas R.M. Oxidative stress in the hippocampus during experimental seizures can be ameliorated with the antioxidant ascorbic acid. Oxidative Medicine and Cellular Longevity 2009, 2:214-221.
76. Sato K., Saito H., Katsuki H. Synergism of tocopherol and ascorbate on the survival of cultured brain neurones. Neuroreport 1993, 4:1179-1182.
77. Savolainen K.M., Loikkanen J., Eerikäinen S., Naarala J. Glutamate-stimulated ROS production in neuronal cultures: interactions with lead and the cholinergic system. Neurotoxicology 1998, 19:669-674.
78. Schmidt A.J., Heiser P., Hemmeter U.M., Krieg J.C., Vedder H. Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells. Progress in Neuropsychopharmacology & Biological Psychiatry 2008, 32:1567-1573.
79. Seale J.V., Wood S.A., Atkinson H.C., Bate E., Lightman S.L., Ingram C.D., et al. Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats. Journal of Neuroendocrinology 2004, 16:516-524.
80. Seregi A., Schaefer A., Komlós M. Protective role of brain ascorbic acid content against lipid peroxidation. Experientia 1978, 34:1056-1057.
81. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85:367-370.
82. Tagliari B., dos Santos T.M., Cunha A.A., Lima D.D., Delwing D., Sitta A., et al. Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats. Journal of Neural Transmission 2010, 117:1067-1076.
83. Traber M.G., Stevens J.F. Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radical Biology & Medicine 2011, 51:1000-1013.
84. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology 2007, 39:44-84.
85. Van-der-Vliet A., Bast A. Effects of oxidative stress on receptors and signal transmission. Chemico-Biological Interactions 1992, 85:95-116.
86. Wendel A. Glutathione peroxidase. Methods in Enzymology 1981, 77:325-333.
87. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
88. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93:358-364.
89. Wilson D.O., Johnson P. Exercise modulates antioxidant enzyme gene expression in rat myocardium and liver. Journal of Applied Physiology 2000, 88:1791-1796.
90. Wong M.L., Licinio J. Research and treatment approaches to depression. Nature Reviews Neuroscience 2001, 2:343-351.